Trexquant Investment’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-35,245
| Closed | -$461K | – | 1815 |
|
2022
Q3 | $461K | Buy |
+35,245
| New | +$461K | 0.02% | 847 |
|
2022
Q2 | – | Sell |
-25,147
| Closed | -$383K | – | 1957 |
|
2022
Q1 | $383K | Buy |
25,147
+6,638
| +36% | +$101K | 0.02% | 893 |
|
2021
Q4 | $328K | Sell |
18,509
-8,622
| -32% | -$153K | 0.02% | 865 |
|
2021
Q3 | $570K | Buy |
+27,131
| New | +$570K | 0.05% | 484 |
|